Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
branded pharmaceuticals
generic pharmaceuticals |
| gptkbp:focusesOn |
ADHD medications
cough and cold medications |
| gptkbp:foundedIn |
2002
|
| gptkbp:founder |
gptkb:Ketan_Mehta
|
| gptkbp:headquartersLocation |
gptkb:Monmouth_Junction,_New_Jersey,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Quillivant_XR
Dyanavel XR Quillichew ER |
| gptkbp:numberOfEmployees |
500-1000
|
| gptkbp:specializesIn |
extended-release drug delivery
liquid and chewable dosage forms |
| gptkbp:website |
https://www.trispharma.com/
|
| gptkbp:bfsParent |
gptkb:Quillivant_XR
gptkb:Dynavel_XR |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tris Pharma
|